Share page on LinkedIn

Financial Times US Pharma and Biotech Summit

5 - 6 May 2021, virtual event

Strategies for growth beyond the COVID-19 pandemic

The Financial Times US Pharma and Biotech Summit brings together industry leaders and experts to share insights and perspectives on how the pharma industry is adapting to meet a new set of challenges and opportunities for the post-pandemic era..

ICON speaker:

Dr. Steve Cutler, ICON Chief Executive Officer

Dr. Steve Cutler

Chief Executive Officer, ICON plc

5 May 2021

2:45pm - 3:05pm EST

Fireside chat
: 'Post Pandemic Opportunities in Clinical Development'

The challenges of the pandemic have pushed CROs and sponsors to embrace new ways of conducting clinical trials that offer significant advantages going forward.  ICON CEO Dr. Steve Cutler discusses these developments in a post-pandemic clinical trials landscape and looks at some of the recent developments in the CRO market.

Featured speakers include:

Alisha Alaimo, President, Biogen U.S.

Karan Arora, Chief Commercial Digital Officer, Global Vice President, AstraZeneca

Stéphane Bancel, CEO, Moderna Therapeutics

Jenn Bonilla, SVP, Portfolio Strategy, Management and Operations, Gilead Sciences

Giovanni Caforio, Chairman and CEO, Bristol Myers Squibb

Courtney Piron, Head, North America Public Affairs, Novartis

Lidia Fonseca, EVP, Chief Digital and Technology Officer, Pfizer

Anne Heatherington, SVP, Head of Data Sciences Institute, Takeda

Aran Maree, CMO, Pharmaceuticals, Johnson & Johnson

MCynthia Pussinen, CTO, Spark Therapeutics

John Reites, CEO, THREAD

Christi Shaw, CEO, Kite

George Yancopoulos, President and CSO, Regeneron